Neurons Lab vs EPAM Systems: full comparison for 2026
Quick verdict
Neurons Lab (4.9/5) edges ahead of EPAM Systems (4.0/5) overall. Neurons Lab is the better choice for enterprises needing senior AI advisory, not a staffing pool. EPAM Systems is the stronger option for large enterprises, $100K+ budgets, publicly-traded global partner. The right choice depends on your project size, budget, and required tech stack.
Neurons Lab vs EPAM Systems: head-to-head summary
| Criterion | Neurons Lab | EPAM Systems |
|---|---|---|
| Founded | 2019 | 1993 |
| HQ | London, United Kingdom | Newtown, Pennsylvania, United States |
| Team size | 51–200 | 50,000+ |
| Rating | 4.9 / 5 | 4.0 / 5 |
| Primary differentiator | Founder-led AI strategy-to-production consultancy with no junior-heavy delivery layer | Public-company (NYSE: EPAM) scale and compliance rigor, with 30+ years of engineering history predating the AI wave |
| Pricing model | Time & materials, fixed-scope advisory sprints | Time & materials, managed engagement |
| Min. engagement | Not published | $100,000+ |
| Primary tech stack | PyTorch, Hugging Face, LangChain | AWS SageMaker, Azure ML, Databricks |
| Industries served | FinTech, Healthcare, Manufacturing, Media & Entertainment, Insurance | FinTech, Healthcare, Retail & E-commerce, Manufacturing, Telecom |
Neurons Lab vs EPAM Systems: overview
Neurons Lab
Neurons Lab is an AI consultancy co-founded in 2019 by Igor Sydorenko and Alex Honchar, headquartered in London. The firm runs end-to-end engagements — from identifying high-impact AI applications through integration and scaling — and reports more than one hundred AI implementations since founding, including work for Fortune 500 firms (per company website; independently unverifiable). Its small, senior-heavy team structure keeps engagements tightly scoped rather than staffed with junior benches.
EPAM Systems
EPAM Systems, Inc. (NYSE: EPAM) has operated since 1993 and has become one of the largest global digital transformation and engineering services providers, with a workforce in the tens of thousands. Its AI development services span generative AI, machine learning consulting, and intelligent automation, delivered by consultants, designers, and engineers who have worked with AI technologies for decades, and Clutch lists a minimum project size of $100,000+ with $150–$199/hr average rates. As a large publicly traded firm, EPAM offers the deepest compliance and financial transparency in this list, at a correspondingly higher entry price point.
Services and capabilities: Neurons Lab vs EPAM Systems
| Capability | Neurons Lab | EPAM Systems |
|---|---|---|
| Custom ML Models | ✓ | ✓ |
| Computer Vision | ✗ | ✗ |
| NLP | ✗ | ✗ |
| MLOps | ✓ | ✓ |
| Generative AI | ✓ | ✓ |
| AI Consulting | ✓ | ✓ |
Tech stack comparison: Neurons Lab vs EPAM Systems
| Framework / platform | Neurons Lab | EPAM Systems |
|---|---|---|
| TensorFlow | N/A | N/A |
| PyTorch | ✓ | N/A |
| AWS | ✓ | ✓ |
| Azure | ✓ | ✓ |
| Google Cloud | N/A | N/A |
| LangChain | ✓ | N/A |
| Hugging Face | ✓ | N/A |
| Kubernetes | N/A | ✓ |
Pricing comparison: Neurons Lab vs EPAM Systems
| Criterion | Neurons Lab | EPAM Systems |
|---|---|---|
| Minimum engagement | Not published | $100,000+ |
| Engagement models | Fixed-scope advisory, Dedicated team, Retainer | Managed engagement, Time & materials, Staff augmentation |
| Rate transparency | Not public | Minimum disclosed |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Neurons Lab vs EPAM Systems
| Dimension | Neurons Lab | EPAM Systems |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | FinTech, Healthcare, Manufacturing | FinTech, Healthcare, Retail & E-commerce |
| Best use cases | Enterprise wants an outside technical opinion before committing budget to an AI initiative., Mid-market company needs a senior AI team to take a use case from prototype to production. | Large enterprise with a $100K+ budget needs a publicly traded vendor for AI/ML procurement compliance requirements., Fortune 500 company needs generative AI deployed at global scale with responsible-AI governance built in. |
| Typical project type | Fixed-scope advisory | Managed engagement |
Neurons Lab vs EPAM Systems: pros and cons
| Neurons Lab | |
|---|---|
| + | Founders are practicing ML engineers (CTO is a published deep learning author), so scoping conversations are technically grounded. |
| + | Small team size means senior staff stay on the engagement instead of rotating off after the pitch. |
| + | Track record spans over 100 AI implementations across regulated and non-regulated sectors since 2019. |
| + | Advisory-first model reduces the risk of over-building before validating an AI use case. |
| - | 51–200 headcount caps how many concurrent enterprise engagements the firm can run. |
| - | No public case study library with quantified before/after metrics — most proof points are narrative. |
| - | Not a fit for teams that need large-scale staff augmentation rather than a scoped advisory engagement. |
| EPAM Systems | |
|---|---|
| + | Publicly traded on the NYSE, giving clients access to audited financial disclosures unavailable from private competitors. |
| + | 50,000+ global workforce provides essentially unlimited delivery capacity for the largest enterprise AI programs. |
| + | 31+ years of engineering history (since 1993) predates the current AI hiring wave by decades. |
| + | AI/generative AI practice spans strategy through production deployment and responsible-AI compliance, covering the full enterprise lifecycle. |
| + | Scale/compliance standout among the researched companies — the clearest choice for regulated, large-budget enterprise programs. |
| - | $100,000+ minimum project size (per Clutch) puts EPAM out of reach for startups and mid-market budgets under six figures. |
| - | $150–$199/hr rate band is among the highest in this list, reflecting large-firm overhead. |
| - | At 50,000+ employees, AI/ML is one practice among dozens — clients should confirm they're getting a dedicated AI pod, not a generalist team. |
Who should choose Neurons Lab?
A typical fit: enterprise wants an outside technical opinion before committing budget to an AI initiative.
Founder-led AI strategy-to-production consultancy with no junior-heavy delivery layer. Minimum engagement starts at Not published. Works best with clients in FinTech, Healthcare, Manufacturing, Media & Entertainment, Insurance.
Who should choose EPAM Systems?
A typical fit: large enterprise with a $100K+ budget needs a publicly traded vendor for AI/ML procurement compliance requirements.
Public-company (NYSE: EPAM) scale and compliance rigor, with 30+ years of engineering history predating the AI wave. Minimum engagement starts at $100,000+. Works best with clients in FinTech, Healthcare, Retail & E-commerce, Manufacturing, Telecom.
Decision matrix: Neurons Lab vs EPAM Systems
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Neurons Lab |
| You need a large dedicated team for an ongoing programme | Neurons Lab |
| Your budget is at the lower end | Compare: Neurons Lab (Not published) vs EPAM Systems ($100,000+) |
| You need specialist depth in a specific vertical | Neurons Lab |
| You need production MLOps support after model launch | Both offer MLOps support |
| You need consulting before committing to a build | Neurons Lab |
Use case fit: Neurons Lab vs EPAM Systems
| Use case | Neurons Lab fit | EPAM Systems fit | Winner |
|---|---|---|---|
| Enterprise wants an outside technical opinion before committing budget to an AI initiative. | Strong | Strong | Both equally |
| Mid-market company needs a senior AI team to take a use case from prototype to production. | Strong | Limited | Neurons Lab |
| Large enterprise with a $100K+ budget needs a publicly traded vendor for AI/ML procurement compliance requirements. | Limited | Strong | EPAM Systems |
| Fortune 500 company needs generative AI deployed at global scale with responsible-AI governance built in. | Limited | Strong | EPAM Systems |
| Fixed-scope ML build | Limited | Limited | Both equally |
| Ongoing model retraining | Limited | Limited | Both equally |
Verdict: Neurons Lab vs EPAM Systems
Neurons Lab (4.9/5) is the stronger overall choice for most Machine Learning Development projects. Founder-led AI strategy-to-production consultancy with no junior-heavy delivery layer.
EPAM Systems (4.0/5) is worth a look if you need fortune 500 company needs generative AI deployed at global scale with responsible-AI governance built in. If your situation matches that, EPAM Systems is a competitive option.
Related comparisons
Neurons Lab vs EPAM Systems FAQ
Is Neurons Lab better than EPAM Systems?
Neurons Lab (4.9/5) scores higher overall, but "better" depends on your use case. Neurons Lab's strongest advantage: founders are practicing ML engineers (CTO is a published deep learning author), so scoping conversations are technically grounded. EPAM Systems's strongest advantage: publicly traded on the NYSE, giving clients access to audited financial disclosures unavailable from private competitors.
How do Neurons Lab and EPAM Systems differ in pricing?
Neurons Lab uses time & materials, fixed-scope advisory sprints pricing with a minimum engagement of Not published. EPAM Systems uses time & materials, managed engagement pricing with a minimum engagement of $100,000+. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Neurons Lab or EPAM Systems?
Neurons Lab is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Neurons Lab and EPAM Systems?
Neurons Lab's primary differentiator is: founder-led AI strategy-to-production consultancy with no junior-heavy delivery layer. EPAM Systems's primary differentiator is: public-company (NYSE: EPAM) scale and compliance rigor, with 30+ years of engineering history predating the AI wave. They also differ in team size (51–200 vs 50,000+), minimum engagement (Not published vs $100,000+), and primary industries served (FinTech, Healthcare vs FinTech, Healthcare).